Catalyst Wire Dossier Catalyst Wire Dossier

RO4905417

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for RO4905417, covering 2016-11-02 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of RO4905417 in Patients With Non ST-Elevation Myocardial Infarction (Non-STEMI) Undergoing Percutaneous Coronary Intervention [Phase 2]

See pricing